December 25, 2024FinancialNotice Concerning Status and Completion of Acquisition of Own Shares, and Cancellation of Treasury Stock (PDF 90.05 KB) (Acquisition of the Company's own shares under articles of incorporation pursuant to the paragraph 2 of Article 165 of the Companies Act of Japan, and cancellation of treasury stock pursuant to the Article 178 of the Companies Act of Japan)
December 03, 2024FinancialNotice Concerning Status of Acquisition of Own Shares (PDF 88.66 KB) (Acquisition of the Company's own shares under articles of incorporation pursuant to the paragraph 2 of Article 165 of the Companies Act of Japan)
December 03, 2024CorporateMulti-Center Superiority Clinical Trial, Supported by Terumo Blood and Cell Technologies, Aims to Significantly Reduce Complications From Acute Chest Syndrome in Adult Sickle Cell Disease Patients
Terumo (China) Holdings Co., Ltd. Room 805, PICC Building 2 Jianguomenwai Street Chaoyang District Beijing, 100022 China
Top
Top